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Abstract Despite the fact that Wegener’s granulomatosis
affects the nasal and paranasal cavities and the cranial nerves
regularly, chemosensory impairments have not been repor-
ted. The objective of this study is to test the three chemo-
sensory systems, olfaction, taste, and intranasal trigeminal
function in Wegener disease patients. We tested olfactory,
gustatory, and intranasal trigeminal function in nine patients
(5 women, 4 men, mean age 57 years) with confirmed
Wegener’s granulomatosis. Olfaction was tested with the
Sniffin’Sticks, gustatory function with the ‘‘Taste strips’’
and intranasal trigeminal function with a lateralization task.
One patient had anosmia (11%), four patients had hyposmia
(44%) and four patients were normosmic (45%). Gustatory
testing function showed pathological taste strip results in
five patients (55%) and normal results in three patients
(33%). One patient did not undergo taste testing. Intranasal
trigeminal function was lowered in five patients (56%) and
normal in four patients (44%). Neither previous nasal sur-
gery status nor endoscopic status was associated to a higher
frequency in pathological scores for any of the three
chemical senses. In conclusion, these preliminary results
suggest a consistent affection in chemosensory functions in
Wegener’s granulomatosis patients.
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Introduction
Wegener’s granulomatosis (WG) is a granulomatous
inflammation of the upper and lower respiratory tract,
which is accompanied by a necrotizing, granulomatous
vasculitis of the medium-sized and small vessels [1]. In
more than 80% of the cases, WG initially manifests clini-
cally in the head and neck region [2]. Wegener’ granulo-
matosis occurs at all ages, but is most frequently diagnosed
from the fourth life decade onwards [3]. In so-called ‘‘Head
Wegener’’, the nose and paranasal sinuses account for the
main localization with 70–90% [4] with a varying degree of
concomitant affection of other organs. Most of these head
WG cases are accompanied by rhinitis, sinusitis, nasal
ulcers, middle ear effusions, and tracheal manifestations.
Besides classical kidney and pulmonary affection [1], WG
has repeatedly been associated with peripheral and cranial
nerve neuropathies [5]. Among the cranial nerves the facial,
optic and abducens nerves are the most concerned, whereas
the first cranial nerve (olfaction) seems not to be concerned
at all [6]. All chemical senses, olfaction, taste, and intra-
nasal trigeminal perception are mediated by cranial nerves
and two chemical senses, olfaction, and intranasal trigem-
inal function are altered by chronic rhino-sinusitis [7].
As WG potentially affects both, the upper airways and
cranial nerves, chemosensory functions might be affected
in these patients. We investigate if, and to which extent the
chemosensory functions were affected in WG.
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Materials and methods
Patients
Nine patients (5 women, 4 men, age median 57 ± 6 years)
with confirmed WG underwent chemosensory examination,
except one patient who did not undergo taste and retronasal
testing. The patient’s history was assessed and nasal
endoscopy was performed after nasal decongestion. An
overview of the patient’s details is given on Table 1. All
patients were treated with cyclophosphamide and/or ste-
roids and had a stable disease state at the moment of
testing. The patients labeled as positive biopsy within
Table 1 showed granulomatous inflammation either within
the arterial wall or in the perivascular area or granuloma-
tous inflammation involving the respiratory tract, and
vasculitis of small and medium sized vessels.
Visual analogical scale ratings
The patients were asked to rate their nasal patency feeling,
olfactory and gustatory function, facial pain, or headache
as well as rhinorrhea on a visual analogical scale. The
scales were labeled from 0 to 10, whereas 0 meant absent
olfactory or gustatory function, non-obstructed breathing
and absence of rhinorrhea or facial pain/headache. On the
other scale end, ten corresponded to completely blocked
nose, severe facial pain/headache and rhinorrhea as well as
outstanding olfactory and gustatory function.
Chemosensory testing
Orthonasal olfaction was tested by using the Sniffin’Sticks,
a well-validated and widespread European smell test kit. It
consists of a threshold, discrimination, and identification
test, summed up to a composite TDI score (for details see
reference [8]). The three subtests do all allow for a maxi-
mum of 16 point each and the total score of can be 48
points. Anosmia is consistent with less than 16 points and
normosmia starts above 30 points. Results in between are
considered to reflect hyposmia.
Retronasal olfaction was assessed using a previously
described 10-item test based on food powders without any
concomitant basic taste properties (e.g. banana flavor
without sweet taste) [9]. Using validated techniques for
application [10] (Iphas Pharma, Wu¨rstelen, Germany)
odors were applied to the oral cavity in the form of odor-
ized but tasteless food powders (Givaudan SA, Du¨bendorf,
Switzerland). While blocking the nose by gently pressing
the wings against the septum, a powder was applied to the
tongue. Once the mouth had been closed, participants were
allowed to unblock the nose. They were then asked to
identify the odor from a list of four items. Following
administration of each powder, participants rinsed their
oral cavity with tap water.
Gustatory function was examined by using the ‘‘taste
strips’’; a clinical identification test based on impregnated
filter papers applied to the anterior two-thirds of the ton-
gue. Normal taste identification is considered when 19 or
more of 32 presented taste strips are correctly identified
(for details see [11]).
Intranasal trigeminal function was assessed by using the
lateralization paradigm, which basically exploits the fact
that molecules that stimulate the trigeminal nerve can be
localized to the nostril they entered the nose whereas this is
not possible for pure odorants. For example, if a subject is
presented vanilla (a substance stimulating solely the
olfactory nerve) to one nostril and odorless air simulta-
neously to the opposite nostril, this subject has a 50%
chance of localizing the nostril where vanilla was pre-
sented. In contrast, if the same is done with menthol
(a substance stimulating the olfactory but also considerably
Table 1 Overview of the patients clinical details
Patient Gender Age Previous
nasal surgery
Nasal
endoscopy
Disease
duration
(years)
c-ANCA Positive
biopsy
Organs affected
1 F 34 Yes Normal 5 Negative Subglottic Trachea, Lung, Ear, Larynx
2 M 58 Yes Normal 7 Positive Renal Lung, Nose, Kidney
3 F 50 Yes Crusts 3 Positive Nasal Ear, Nose
4 M 68 No Normal 9 Positive Nasal Nose
5 F 77 Yes Septal perforation 3 Positive Nasal Nose, Heart, Spleen Cranial Nerve VI
6 F 37 Yes Synechia 9 Positive Nasal Nose
7 F 67 Yes Crusts 26 Negative Nasal Nose, Trachea
8 M 42 No Mucosal congestion 1 Positive Bronchial Nose, Trachea, Lung, Cranial Nerve XII, Ear
9 M 87 No Normal 2 Positive Nasal Nose, Lung, Kidney
M male, F female
1090 Eur Arch Otorhinolaryngol (2010) 267:1089–1093
123
the intranasal trigeminal nerve) the subjects chance to
localize correctly rise up to 90%. This difference in accu-
racy of detecting from which side a stimulus comes
according to whether the substance has trigeminal proper-
ties or not is currently considered the best available psy-
chophysical test to examine intranasal trigeminal function
[12]. We used the same clinical procedure previously
described by Hummel et al. [13], who presented eucalyptol
odor to either one nostril in a high-density polyethylene
squeeze bottle (250 ml) filled with 30 ml of eucalyptol (a
substance stimulating the olfactory but especially the
intranasal trigeminal nerve); at the same time, an identical
bottle filled with 30 ml of odorless propylene glycol was
presented to the contralateral nostril. A total of 40 stimuli
were applied to the blindfolded patients in a pseudo-ran-
domized sequence. After each stimulus, patients were
asked to identify the nostril where the odorant had been
presented. The sum of correct identifications reflects the
intranasal trigeminal function and was used for further
statistical analyses.
Statistics
The results are shown as mean value and their standard
error of the mean (±SEM). The statistical evaluation was
conducted using SPSS 16. For comparison of mean, we
used nonparametric statistics Mann–Whitney test and
Wilcoxon rank test to compare ortho versus retronasal
olfactory function. Correlations were calculated using the
Spearman correlation. Analyses of frequencies were cal-
culated using Chi-Square tests. The alpha-level was set at
0.05.
Results
Patient’s chemosensory function
Based on TDI scores, one patient had anosmia (11%), four
patients had hyposmia (44%) and four patients were nor-
mosmic (45%). Retronasal screening testing showed three
patients with lowered scores and five patients with normal
scores. Gustatory testing function showed pathological
taste strip results in five patients (55%) and normal results
in three patients (33%). One patient did not undergo ret-
ronasal and gustatory testing (Table 2). Intranasal trigem-
inal function, measured with the lateralization task, was
lowered in five patients and normal in four patients. Nei-
ther previous nasal surgery status nor endoscopic status
were associated to a higher frequency in pathological TDI
scores (v2 test, P = 0.3; v2 test, P = 0.2), taste strip scores
(v2 test, P = 0.1; v2 test, P = 0.7) or lateralization scores
(v2 test, P = 0.4; v2 test, P = 0.3). Ortho versus retronasal
olfactory function was not found to be significantly dif-
ferent (Z = -0.98, P = 0.4).
Age and disease duration effect
There was no significant effect for age or disease duration
on the chemosensory function. Age did not correlate sig-
nificantly with TDI score (r9 = -0.6; P = 0.09); taste
strip score (r9 = 0.1; P = 0.7) or localization scores rep-
resenting intranasal trigeminal function (r9 = 0.7;
P = 0.8). Disease duration did not correlate significantly
with TDI score (r9 = 0.3; P = 0.3); taste strip score
(r9 = 0.1; P = 0.6) or localization scores representing
intranasal trigeminal function (r9 = 0.6; P = 0.8).
Subjective ratings
Ratings of olfactory function correlated significantly with
the TDI scores (r9 = 0.8; P = 0.01), whereas taste
(r9 = 0.5; P = 0.2) and intranasal trigeminal function
ratings (r9 = 0.3; P = 0.5) did not correlate with the
respective psychophysical results. Interestingly, ratings of
olfactory and taste function correlated (r9 = 0.8;
P = 0.01). Patients with previous nasal surgery and also
those with pathological endoscopic scores rated their nasal
obstruction worse than those who did not have prior sur-
gery (Z = -2; P = 0.04; Z = -1.9, P = 0.05).
Nasal affection
6 of the 9 patients had received operations on the outside of
the nose and/or the paranasal sinuses prior to diagnosis. In
5 out of these 6 cases, a possible WG had not been
suspected. Instead, there had been symptoms of chronic
rhino-sinusitis which were intended to be remedied by an
operation. In these patients, postoperative wound healing
problems such as encrusted mucous secretion, synechiae,
Table 2 Overview of the patients chemosensory results
Patient Olfaction
(TDI score)
Retronasal
olfaction
(percent
correct)
Trigeminal function
(lateralization score
out of 40 possible)
Taste
(taste strip
score)
1 39.5 100 31 27
2 31.25 50 23 23
3 23.25 70 27 12
4 37.75 90 34 18
5 6 70 21 14
6 28.5 80 34 24
7 25.5 90 15 4
8 30.5 100 20 9
9 21.5 Not tested 34 Not tested
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large septum perforation, or histological report of the
removed tissue suggested the presence of WG. In four
cases, endoscopic examination revealed no pathological
findings. 2 out of 9 patients had an isolated affection of the
nose, and all 9 patients had at least another head and neck
manifestation.
Discussion
The present study suggests that patients with WG show
lowered overall chemosensory functions. To our knowl-
edge, this is the first study which focussed on chemosen-
sory function in WG patients. Two previous case reports
[14, 15] and one large series on cranial nerve involvement
in Wegener disease mention anecdotally chemosensory
symptoms without having measured and them [16].
Recently, Laudien et al. [17] also screened WG patients for
olfactory identification suggesting that up to 18% of them
had lowered olfactory identification scores. Unfortunately,
these authors did not test the other chemical senses and
were able do asses the full Sniffin’ Sticks test battery only
in 4 out of 76 WG patients. In general, WG affects the
nasal and paranasal cavities and cranial nerves and should
consequently also lead to chemosensory (olfactory, gusta-
tory or trigeminal) deficits since all of them are mediated
by cranial nerves. Astonishingly, cranial nerve affection in
Wegener disease has been described for the cranial nerves
II–XII whereas optic, abducens, and facial nerve are the
most concerned [6]. In contrast, cranial nerve I affection
(olfactory) has been mentioned without any further detail
in solely one publication [16]. Here, using well-established
measurement tools, we have almost half of the patients
who have lowered olfactory scores, which seem to cor-
roborate the findings from the above-mentioned screening
study [17]. The mechanisms of cranial nerve involvement
may be either by continuity, especially from nasal and skull
base granulomas, or by vasculitic involvement of small
vessels surrounding the cranial nerves, resulting in mono-
neuritis multiplex [6]. Since nasal affection did not reveal
to be a significant factor associated to olfactory function
the first mechanism seems rather unlikely. Since no
olfactory epithelium or nerve biopsies were available for
the present WG patients, it remains speculative to assume
mononeuritis multiplex for the first cranial nerve.
Besides the description of our findings, we attempted to
analyse our data statistically. Considering the small sample
size, we are aware that such an analysis has only limited
meaningfulness. Larger prospective studies on WG and
chemosensory functions must further confirm our findings.
Statistical sub-analysis suggests that the chemosensory
affections in WG are not related to the sinunasal affection
or prior surgery status. Although statistics do not establish
a clear link between chronic nasal involvements and
chemosensory functions, we dare to speculate that the
possibility of chronic nasal affection as a key factor for
chemosensory decrease should not be ruled out. Here, 6 out
of 9 patients had nasal surgery before diagnosis was
established because of chronic rhinosinusitis symptoms,
which reflects the high percentage of nasal involvement in
WG. Thus, chronic nasal mucosal inflammation could be a
major contributor to chemosensory impairment even
though the present results do not underline that. Nasal
surgery itself and the prolonged and complicated wound
healing observed in some patients could also account for
chemosensory affection. In contrast to previous studies
[18], and based on the self-ratings, we also found that
Wegener disease patients seemed to be aware of their
olfactory deficits. Since rating of olfactory function and
nasal patency is often confounded [18, 19], this could be
further hint that the olfactory lowering found here is sin-
unasal disease related. Alternatively, cranial nerve affec-
tion in WG could be a reason for observed chemosensory
changes. However, most patients had no cranial nerve
symptoms and we think that it is rather unlikely that silent
cranial nerve affection (e.g. such as mononeuritis multiplex
of the olfactory nerve) caused the chemosensory impair-
ments. Larger studies must confirm implication of the first
cranial nerve in WG and this high preliminary rate of
olfactory disorders. Finally, like in other autoimmune dis-
eases [20–22], unknown, maybe systemic factors could
contribute to a lowering of the chemosensory function.
Since renal insufficiency is known to alter smell and taste
function [23], this could account for lowered chemosensory
functions in WG patients.
Gustatory function was also found to be affected in more
than half of the patients, which is surprising since the
patient’s ratings did not suggest any taste problem. WG
affects preferentially the seventh cranial nerve but also the
middle ear cavity. Thus, the chorda tympani function,
which was measured here, could be affected due to direct
seventh cranial nerve involvement or direct middle ear
inflammation, known to affect taste function [24]. In the
present study, only three of the five patients with impaired
taste results had middle ear disease or cranial nerve
affection. Besides these direct disease related reasons, taste
is also more susceptible to medication and we cannot
completely rule out medication side effects especially from
the cyclophosphamide [25], which all patients had received
during the disease course. Finally, intranasal trigeminal
function was tested here and showed similar rates of
impairment as olfactory and gustatory function. Like for
olfactory function, statistical analysis did also not reveal
any significant link between nasal involvement, prior nasal
surgery and endoscopic findings and trigeminal impair-
ment. Similar to olfaction, intranasal trigeminal function
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could be altered due to nasal involvement of Wegener
disease. Silent trigeminal affection by Wegener disease
itself is unlikely since no patient complained about other
trigeminal symptoms, such as facial pain or sensory
deficits.
Despite the thorough chemosensory workup of these
WG patients, our study has several limitations: first, the
study sample was small, which is also due to the relative
rareness of the investigated disease. Second, the study
provides an interesting observation, that of high frequency
of overall chemosensory dysfunction in WG patients,
without providing or proposing an identifiable cause or
mechanism. Finally, the present data, although they largely
corroborate very recently made observations of Laudien
et al. [17], remain still inconclusive when it comes to
characterize the nature of the chemosensory disorder WG
patients have.
Conclusion
The present study revealed that chemical senses are con-
sistently and to a comparable extent affected in WG. Based
on this transitional study, it is difficult to identify a clear
cause for the unexpectedly high rate of chemosensory
impairment. Further studies with larger samples must
confirm our preliminary data.
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